SEC Form 4 · accession 0001731122-18-000139
Enochian Biosciences Inc · ENOB
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Rene Sindlev
Director · 10% Owner
Period of report
Sep 19, 2018
Accepted (ET)
Nov 7, 2018 · 9:12 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001527728
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Option to Purchase Common Stock | $5.74 | Sep 19, 2018 | A | 7,840 | A | Jul 30, 2019 | Sep 19, 2028 | Common Stock | 7,840 | 7,840 | D |